Canner David has filed 4 insider transactions across 1 company since October 2024.
Most recent transaction: a grant/award of 108176 shares of Inhibikase Therapeutics, Inc. ($IKT) on June 30, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 30, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Canner David | Not found | A | Stock Option (Right to Buy) | 108176 | $0.00 | 108,176.0000 | 23,712,220 | 9999.99% | 0.46% |
| Feb. 14, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Canner David | Not found | A | Stock Option (Right to Buy) | 22640 | $0.00 | 22,640.0000 | 23,712,220 | 9999.99% | 0.10% |
| Feb. 14, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Canner David | Not found | A | Stock Option (Right to Buy) | 116585 | $0.00 | 116,585.0000 | 23,712,220 | 9999.99% | 0.49% |
| Oct. 21, 2024 | Inhibikase Therapeutics, Inc. | $IKT | Canner David | Not found | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 8,882,570 | 9999.99% | 0.68% |